Haider MR - Search Results

1

A review on anticancer potential of bioactive heterocycle quinoline.

Afzal O, Kumar S, Haider MR, Ali MR, Kumar R, Jaggi M, Bawa S. Afzal O, et al. Among authors: haider mr. Eur J Med Chem. 2015 Jun 5;97:871-910. doi: 10.1016/j.ejmech.2014.07.044. Epub 2014 Jul 24. Eur J Med Chem. 2015. PMID: 25073919 Review.

2

Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities.

Akhtar MJ, Yar MS, Khan AA, Ali Z, Haider MR. Akhtar MJ, et al. Among authors: haider mr. Mini Rev Med Chem. 2017;17(17):1602-1632. doi: 10.2174/1389557516666161031121639. Mini Rev Med Chem. 2017. PMID: 27804888 Review.

3

DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective.

Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS. Pathak A, et al. Among authors: haider mr, haider k. Eur J Med Chem. 2018 Oct 5;158:559-592. doi: 10.1016/j.ejmech.2018.08.093. Epub 2018 Sep 11. Eur J Med Chem. 2018. PMID: 30243157 Review.

4

Free radical scavengers: An overview on heterocyclic advances and medicinal prospects.

Haider K, Haider MR, Neha K, Yar MS. Haider K, et al. Among authors: haider mr. Eur J Med Chem. 2020 Oct 15;204:112607. doi: 10.1016/j.ejmech.2020.112607. Epub 2020 Jul 15. Eur J Med Chem. 2020. PMID: 32721784 Review.

5

Medicinal prospects of antioxidants: A review.

Neha K, Haider MR, Pathak A, Yar MS. Neha K, et al. Among authors: haider mr. Eur J Med Chem. 2019 Sep 15;178:687-704. doi: 10.1016/j.ejmech.2019.06.010. Epub 2019 Jun 13. Eur J Med Chem. 2019. PMID: 31228811 Review.

6

Synthetic strategy and SAR studies of C-glucoside heteroaryls as SGLT2 inhibitor: A review.

Haider K, Pathak A, Rohilla A, Haider MR, Ahmad K, Yar MS. Haider K, et al. Among authors: haider mr. Eur J Med Chem. 2019 Dec 15;184:111773. doi: 10.1016/j.ejmech.2019.111773. Epub 2019 Oct 12. Eur J Med Chem. 2019. PMID: 31630053 Review.

7

Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.

Naaz F, Haider MR, Shafi S, Yar MS. Naaz F, et al. Among authors: haider mr. Eur J Med Chem. 2019 Jun 1;171:310-331. doi: 10.1016/j.ejmech.2019.03.025. Epub 2019 Mar 14. Eur J Med Chem. 2019. PMID: 30953881 Review.

8

Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells.

Haider MR, Ahmad K, Siddiqui N, Ali Z, Akhtar MJ, Fuloria N, Fuloria S, Ravichandran M, Yar MS. Haider MR, et al. Bioorg Chem. 2019 Jul;88:102962. doi: 10.1016/j.bioorg.2019.102962. Epub 2019 May 3. Bioorg Chem. 2019. PMID: 31085373

9

Indole derivatives (2010-2020) as versatile tubulin inhibitors: synthesis and structure-activity relationships.

Naaz F, Neha K, Haider MR, Shafi S. Naaz F, et al. Among authors: haider mr. Future Med Chem. 2021 Oct;13(20):1795-1828. doi: 10.4155/fmc-2020-0385. Epub 2021 Sep 1. Future Med Chem. 2021. PMID: 34468201 Review.

10

Design, synthesis, and biological evaluation of imidazopyridine-linked thiazolidinone as potential anticancer agents.

Iqbal MA, Husain A, Alam O, Khan SA, Ahmad A, Haider MR, Alam MA. Iqbal MA, et al. Among authors: haider mr. Arch Pharm (Weinheim). 2020 Oct;353(10):e2000071. doi: 10.1002/ardp.202000071. Epub 2020 Jul 6. Arch Pharm (Weinheim). 2020. PMID: 32627909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters